IDEXX Laboratories, Inc. (IDXX) financial statements (2022 and earlier)

Company profile

Business Address ONE IDEXX DRIVE
WESTBROOK, ME 04092-2041
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14438490124472392343
Cash and cash equivalents14438490124188155129
Short-term investments    284237214
Receivables368331269249235204188
Inventory, net of allowances, customer advances and progress billings269210195173164158189
Inventory269210195173164158189
Other current assets1741381251081019162
Other undisclosed current assets      40
Total current assets:9561,063680654972846822
Noncurrent Assets
Operating lease, right-of-use asset1059181
Property, plant and equipment588555534437379357333
Intangible assets, net (including goodwill)458296298256244224235
Goodwill359243240214200178179
Intangible assets, net (excluding goodwill)99535842444656
Other noncurrent assets33029024019011910385
Total noncurrent assets:1,4821,2321,153883741685653
TOTAL ASSETS:2,4372,2951,8321,5371,7131,5311,475
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities575490395330320296258
Accounts payable116757270676053
Accrued liabilities459416323261253236206
Deferred revenue404341
Debt7550289399655611573
Deferred revenue and credits292726
Contract with customer, liability41
Other undisclosed current liabilities74      
Total current liabilities:7645837257701,005935857
Noncurrent Liabilities
Long-term debt and lease obligation863936766601606593597
Long-term debt, excluding current maturities775858699601606593597
Operating lease, liability877767
Liabilities, other than long-term debt121143163146157111105
Deferred revenue and credits363327
Deferred revenue414649
Contract with customer, liability61
Deferred tax liabilities, net 253949
Deferred income tax liabilities91233
Other liabilities71868185963929
Other undisclosed noncurrent liabilities   29   
Total noncurrent liabilities:9841,079929776763704702
Total liabilities:1,7471,6621,6551,5471,7671,6391,559
Stockholders' equity
Stockholders' equity attributable to parent, including:690632177(10)(54)(108)(84)
Common stock11111111101010
Treasury stock, value(3,571)(2,800)(2,601)(2,289)(1,912)(1,633)(1,316)
Additional paid in capital1,3771,2951,2141,1381,0741,012941
Accumulated other comprehensive loss(53)(54)(46)(42)(36)(43)(42)
Retained earnings2,9202,1761,5961,168804540318
Other undisclosed stockholders' equity attributable to parent6545665
Stockholders' equity attributable to noncontrolling interest 100000
Total stockholders' equity:690633178(9)(54)(108)(84)
TOTAL LIABILITIES AND EQUITY:2,4372,2951,8321,5371,7131,5311,475

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues3,2152,7072,4072,2131,9691,7751,602
Revenue, net1,9691,7751,602
Cost of revenue(1,326)(1,136)(1,041)(972)(872)(800)(712)
Cost of goods and services sold    (872)(800)(712)
Gross profit:1,8891,5711,3661,2421,097975890
Operating expenses(957)(877)(813)(750)(684)(625)(590)
Operating income:932695553491413350300
Interest and debt expense(30)(33)(31)(35)(37)(32)(29)
Other undisclosed income from continuing operations before equity method investments, income taxes 101542
Income from continuing operations before equity method investments, income taxes:902662522458381322273
Other undisclosed income from continuing operations before income taxes0      
Income from continuing operations before income taxes:903662522458381322273
Income tax expense(158)(80)(94)(81)(118)(100)(81)
Net income:745582428377263222192
Net income (loss) attributable to noncontrolling interest0(0)(0)(0)(0)(0)(0)
Net income available to common stockholders, diluted:745582428377263222192

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:745582428377263222192
Other comprehensive income (loss)0(7)(4)(5)7(1)(34)
Comprehensive income:745575423372270221158
Comprehensive income (loss), net of tax, attributable to noncontrolling interest0(0)(0)(0)(0)(0)(0)
Comprehensive income, net of tax, attributable to parent:745574423372270221158

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: